Literature DB >> 23529132

Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.

Hanyu Liang1, Puntip Tantiwong, Apiradee Sriwijitkamol, Karthigayan Shanmugasundaram, Sumathy Mohan, Sara Espinoza, Ralph A Defronzo, John J Dubé, Nicolas Musi.   

Abstract

Free fatty acids (FFAs) have been implicated in the pathogenesis of insulin resistance. Reducing plasma FFA concentration in obese and type 2 diabetic (T2DM) subjects improves insulin sensitivity. However, the molecular mechanism by which FFA reduction improves insulin sensitivity in human subjects is not fully understood. In the present study, we tested the hypothesis that pharmacological FFA reduction enhances insulin action by reducing local (muscle) inflammation, leading to improved insulin signalling. Insulin-stimulated total glucose disposal (TGD), plasma FFA species, muscle insulin signalling, IBα protein, c-Jun phosphorylation, inflammatory gene (toll-like receptor 4 and monocyte chemotactic protein 1) expression, and ceramide and diacylglycerol (DAG) content were measured in muscle from a group of obese and T2DM subjects before and after administration of the antilipolytic drug acipimox for 7 days, and the results were compared to lean individuals. We found that obese and T2DM subjects had elevated saturated and unsaturated FFAs in plasma, and acipimox reduced all FFA species. Acipimox-induced reductions in plasma FFAs improved TGD and insulin signalling in obese and T2DM subjects. Acipimox increased IBα protein (an indication of decreased IB kinase-nuclear factor B signalling) in both obese and T2DM subjects, but did not affect c-Jun phosphorylation in any group. Acipimox also decreased inflammatory gene expression, although this reduction only occurred in T2DM subjects. Ceramide and DAG content did not change. To summarize, pharmacological FFA reduction improves insulin signalling in muscle from insulin-resistant subjects. This beneficial effect on insulin action could be related to a decrease in local inflammation. Notably, the improvements in insulin action were more pronounced in T2DM, indicating that these subjects are more susceptible to the toxic effect of FFAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23529132      PMCID: PMC3690693          DOI: 10.1113/jphysiol.2012.247510

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  50 in total

1.  Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes.

Authors:  J Denis McGarry
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

Review 2.  The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.

Authors:  G Frühbeck; J Gómez-Ambrosi; F J Muruzábal; M A Burrell
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-06       Impact factor: 4.310

Review 3.  Biochemistry of endotoxins.

Authors:  C R Raetz
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects.

Authors:  Young-Bum Kim; Theodore P Ciaraldi; Alice Kong; Dennis Kim; Neelima Chu; Pharis Mohideen; Sunder Mudaliar; Robert R Henry; Barbara B Kahn
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

Authors:  K Cusi; K Maezono; A Osman; M Pendergrass; M E Patti; T Pratipanawatr; R A DeFronzo; C R Kahn; L J Mandarino
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects.

Authors:  G Boden; B Lebed; M Schatz; C Homko; S Lemieux
Journal:  Diabetes       Date:  2001-07       Impact factor: 9.461

7.  Pharmacokinetics of acipimox and of its N-deoxy metabolite following single and repeated oral administration to healthy volunteers.

Authors:  C Efthymiopoulos; M Strolin Benedetti; I Poggesi; F Ruff; G Basileo; L Musatti
Journal:  Therapie       Date:  1993 Jan-Feb       Impact factor: 2.070

8.  Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha.

Authors:  Samar I Itani; Neil B Ruderman; Frank Schmieder; Guenther Boden
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

9.  Effects of prolonged Acipimox treatment on glucose and lipid metabolism and on in vivo insulin sensitivity in patients with non-insulin dependent diabetes mellitus.

Authors:  A A Vaag; H Beck-Nielsen
Journal:  Acta Endocrinol (Copenh)       Date:  1992-10

10.  Turnover of ethyl-linoleate in rat plasma and its distribution in various organs.

Authors:  B L Hungund; Z Zheng; A I Barkai
Journal:  Alcohol Clin Exp Res       Date:  1995-04       Impact factor: 3.455

View more
  22 in total

1.  Immune and Inflammatory Signaling Pathways in Exercise and Obesity.

Authors:  Karsten Krüger; Frank C Mooren; Klaus Eder; Robert Ringseis
Journal:  Am J Lifestyle Med       Date:  2014-10-27

2.  Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort.

Authors:  Luke W Johnston; Stewart B Harris; Ravi Retnakaran; Adria Giacca; Zhen Liu; Richard P Bazinet; Anthony J Hanley
Journal:  Diabetologia       Date:  2017-12-24       Impact factor: 10.122

3.  Adipose triglyceride lipase deletion from adipocytes, but not skeletal myocytes, impairs acute exercise performance in mice.

Authors:  John J Dubé; Mitch T Sitnick; Gabriele Schoiswohl; Rachel C Wills; Mahesh K Basantani; Lingzhi Cai; Thomas Pulinilkunnil; Erin E Kershaw
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-03-17       Impact factor: 4.310

4.  Impact of Acipimox Therapy on Free Fatty Acid Efflux and Endothelial Function in the Metabolic Syndrome: A Randomized Trial.

Authors:  Aaron W Aday; Allison B Goldfine; Justin M Gregory; Joshua A Beckman
Journal:  Obesity (Silver Spring)       Date:  2019-10-01       Impact factor: 5.002

Review 5.  Muscle atrophy in patients with Type 2 Diabetes Mellitus: roles of inflammatory pathways, physical activity and exercise.

Authors:  Ben D Perry; Marissa K Caldow; Tara C Brennan-Speranza; Melissa Sbaraglia; George Jerums; Andrew Garnham; Chiew Wong; Pazit Levinger; Muhammad Asrar Ul Haq; David L Hare; S Russ Price; Itamar Levinger
Journal:  Exerc Immunol Rev       Date:  2016       Impact factor: 6.308

6.  Elevated nocturnal NEFA are an early signal for hyperinsulinaemic compensation during diet-induced insulin resistance in dogs.

Authors:  Josiane L Broussard; Cathryn M Kolka; Ana V B Castro; Isaac Asare Bediako; Rebecca L Paszkiewicz; Edward W Szczepaniak; Lidia S Szczepaniak; Kristen L Knutson; Stella P Kim; Richard N Bergman
Journal:  Diabetologia       Date:  2015-08-09       Impact factor: 10.122

7.  Diminished anabolic signaling response to insulin induced by intramuscular lipid accumulation is associated with inflammation in aging but not obesity.

Authors:  Donato A Rivas; Devin J McDonald; Nicholas P Rice; Prashanth H Haran; Gregory G Dolnikowski; Roger A Fielding
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-01-13       Impact factor: 3.619

8.  Sphingolipid changes do not underlie fatty acid-evoked GLUT4 insulin resistance nor inflammation signals in muscle cells.

Authors:  Nicolas J Pillon; Scott Frendo-Cumbo; Maya R Jacobson; Zhi Liu; Paul L Milligan; Hai Hoang Bui; Juleen R Zierath; Philip J Bilan; Joseph T Brozinick; Amira Klip
Journal:  J Lipid Res       Date:  2018-05-23       Impact factor: 5.922

9.  ω-3PUFA supplementation ameliorates adipose tissue inflammation and insulin-stimulated glucose disposal in subjects with obesity: a potential role for apolipoprotein E.

Authors:  James D Hernandez; Ting Li; Cassandra M Rau; William E LeSuer; Panwen Wang; Dawn K Coletta; James A Madura; Elizabeth A Jacobsen; Eleanna De Filippis
Journal:  Int J Obes (Lond)       Date:  2021-03-22       Impact factor: 5.095

10.  Insulin-Stimulated Muscle Glucose Uptake and Insulin Signaling in Lean and Obese Humans.

Authors:  Paola A Ramos; Kelli A Lytle; Danae Delivanis; Søren Nielsen; Nathan K LeBrasseur; Michael D Jensen
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.